ANTAGEN BIOSCIENCES INC
BOSTON, MASSACHUSETTS 021182518
Minority Owned
$300K
Total Contract Value
7 awards
First Award
Apr 22, 2022
Last Award
Nov 1, 2023
Business Size
small
CAGE Code
59GJ1
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $300K | 3 |
| 541714 | $0 | 3 |
| 541711 | $0 | 1 |
Contract Awards
1 awards found
75N93022C00011
Department of Health and Human Services
$300K
Jun 24, 2022
THE GOAL OF THE PROPOSED PROJECT IS TO FURTHER DEVELOP ANTAGEN'S NOVEL PROTEIN NANOPARTICLE-BASED EXPRESSION AND DELIVERY SYSTEM USING FCRIDER TECHNOLOGY AND ANTIBODY AFUCOSYLATION TECHNOLOGY TO PRODUCE A2,6-SIALYLATED AFUCOSYLATED ENV-FCRIDER (
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2022
Business Details
- UEI
- HXD6EFH2ND57
- CAGE Code
- 59GJ1
- Address
- 650 ALBANY ST UNIT 112
BOSTON, MA 021182518 - Congressional District
- MA-07
- Phone
- 6176380315
Parent Company
ANTAGEN BIOSCIENCES INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov